HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying-Ping Xu Selected Research

bu-shen-ning-xin

1/2015Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.
1/2015Bu-Shen-Ning-Xin Decoction ameliorated the osteoporotic phenotype of ovariectomized mice without affecting the serum estrogen concentration or uterus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying-Ping Xu Research Topics

Disease

2Keloid
01/2021 - 01/2019
2Skin Diseases (Skin Disease)
01/2021 - 11/2012
2Postmenopausal Osteoporosis
01/2015 - 01/2015
1Fibrosis (Cirrhosis)
12/2022
1Bone Resorption
01/2015
1Neoplasms (Cancer)
11/2012
1Allergic Contact Dermatitis
11/2012

Drug/Important Bio-Agent (IBA)

2RNA (Ribonucleic Acid)IBA
12/2022 - 01/2021
2bu-shen-ning-xinIBA
01/2015 - 01/2015
1MicroRNAs (MicroRNA)IBA
12/2022
1CollagenIBA
01/2021
1Deubiquitinating EnzymesIBA
01/2019
1TNF Receptor-Associated Factor 4IBA
01/2019
1NFATC Transcription FactorsIBA
01/2015
1Estrogen ReceptorsIBA
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Histone Deacetylase InhibitorsIBA
11/2012
1trichostatin A (A 300)IBA
11/2012
1theasinensin AIBA
11/2012
1DinitrofluorobenzeneIBA
11/2012
1Histone Deacetylases (Histone Deacetylase)IBA
11/2012

Therapy/Procedure

2Ovariectomy (Oophorectomy)
01/2015 - 01/2015
1Therapeutics
01/2019